Yes, I am expecting an announcement either latest by tomorrow or Monday next week. Can't be too far away now. Unless the scan and test comes up with something left field that needs further clarification. For example, that first patient would have been more than 2 months since dosage. Who knows, they might see much more than anticipated. One never know because as has been said before, this is a 1 in a 10,000 trial where IMU is allowed to dose on real patient rather than healthy patient.
But one thing I am most confident of is toxicity. If there is any adverse effect, we would have heard of it by now. Since there is no news on that front, then this very trial on toxicity and tolerability would pass. Just a matter of a potential bonus of efficacy.
Fingers and toes crossed for good news.
IMU Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
